Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Agellan Commercial Real Estate Investment Trust ACRVF

"Agellan Commercial Real Estate Investment Trust is an open-ended real estate investment. It is engaged in acquiring and owning industrial, office and retail properties. The company operates through geographic segments that include Canada and the United States of America (USA). The USA region generates maximum revenue for the company."

GREY:ACRVF - Post Discussion

View:
Post by maypeters on Aug 22, 2017 8:12pm

BMO analyst comments

not a shareholder but maybe this helps

Troy MacLean, analyst at BMO Capital Markets, trimmed his target on Agellan Commercial REIT (ACR.UN-T) units to $12.25 from $12.40 and kept his “outperform” rating.

“We continue to like the REIT's discounted valuation, and attractive about 7 per cent yield,” he wrote in a research note. “We have modestly reduced our FFO [funds from operations] estimates for 2017 and 2018 to reflect new foreign exchange assumptions. Our 2018 AFFO [adjusted funds from operations] estimate is also revised due to changes in our foreign exchange assumptions and higher straight-line revenue. Our NAV [net asset value] estimate is unchanged at $12.25/unit.”

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities